Literature DB >> 14712222

Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89.

Yongzhong Wu1, Iman Diab, Xueping Zhang, Elena S Izmailova, Zendra E Zehner.   

Abstract

Vimentin exhibits a complex pattern of developmental- and tissue-specific expression and is aberrantly expressed in most metastatic tumors. The human vimentin promoter contains multiple DNA elements, some of which enhance gene expression and one that inhibits. A silencer element (at -319) binds the repressor ZBP-89. Further upstream (at -757) is an element, which acts positively in the presence of the silencer element and, thus, is referred to as an antisilencer (ASE). Previously, we showed that Stat1alpha binds to this element upon induction by IFN-gamma. However, substantial binding and reporter gene activity was still present in nontreated cells. Here, we have found that Stat3 binds to the ASE element in vitro. Transfection experiments in COS-1 cells with various vimentin promoter--reporter constructs show that gene activity is dependent upon the cotransfection and activation of Stat3. Moreover, activated Stat3 can overcome ZBP-89 repression. Coimmunoprecipitation studies demonstrate that Stat3 and ZBP-89 can interact and confocal microscopy detects these factors to be colocalized in the nucleus. Moreover, a correlation exists between the presence of activated Stat3 and vimentin expression in MDA-MB-231 cells, which is lacking in MCF7 cells where vimentin is not expressed. In the light of these results, we propose that the interaction of Stat3 and ZBP-89 may be crucial for overcoming the effects of the repressor ZBP-89, which suggests a novel mode for Stat3 gene activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14712222     DOI: 10.1038/sj.onc.1207003

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members.

Authors:  Yongzhong Wu; Xueping Zhang; Morgan Salmon; Xia Lin; Zendra E Zehner
Journal:  Biochim Biophys Acta       Date:  2006-12-06

2.  Identification of a novel vimentin promoter and mRNA isoform.

Authors:  Zhangle Zhou; Søren Kahns; Anders Lade Nielsen
Journal:  Mol Biol Rep       Date:  2009-08-19       Impact factor: 2.316

3.  Cell death induced by the Jak2 inhibitor, G6, correlates with cleavage of vimentin filaments.

Authors:  Anurima Majumder; Annet Kirabo; Kanchana Karrupiah; Shigeharu Tsuda; Jennifer Caldwell-Busby; Arturo J Cardounel; György M Keseru; Peter P Sayeski
Journal:  Biochemistry       Date:  2011-08-17       Impact factor: 3.162

4.  Gene loci associated with insulin secretion in islets from non-diabetic mice.

Authors:  Mark P Keller; Mary E Rabaglia; Kathryn L Schueler; Donnie S Stapleton; Daniel M Gatti; Matthew Vincent; Kelly A Mitok; Ziyue Wang; Takanao Ishimura; Shane P Simonett; Christopher H Emfinger; Rahul Das; Tim Beck; Christina Kendziorski; Karl W Broman; Brian S Yandell; Gary A Churchill; Alan D Attie
Journal:  J Clin Invest       Date:  2019-07-25       Impact factor: 14.808

5.  Induction of STAT3-related genes in fast degenerating cone photoreceptors of cpfl1 mice.

Authors:  K Schaeferhoff; S Michalakis; N Tanimoto; M D Fischer; E Becirovic; S C Beck; G Huber; N Rieger; O Riess; B Wissinger; M Biel; M W Seeliger; M Bonin
Journal:  Cell Mol Life Sci       Date:  2010-05-14       Impact factor: 9.261

6.  Suppression of the Growth and Invasion of Human Head and Neck Squamous Cell Carcinomas via Regulating STAT3 Signaling and the miR-21/β-catenin Axis with HJC0152.

Authors:  Yu Wang; Sinan Wang; Yansheng Wu; Yu Ren; Zhaoqing Li; Xiaofeng Yao; Chao Zhang; Na Ye; Chao Jing; Jiabin Dong; Kailiang Zhang; Shanshan Sun; Minghui Zhao; Wenyu Guo; Xin Qu; Yu Qiao; Haiying Chen; Lingping Kong; Rui Jin; Xudong Wang; Lun Zhang; Jia Zhou; Qiang Shen; Xuan Zhou
Journal:  Mol Cancer Ther       Date:  2017-01-30       Impact factor: 6.261

7.  TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome.

Authors:  Ian A Myles; Erik D Anderson; Noah J Earland; Kol A Zarember; Inka Sastalla; Kelli W Williams; Portia Gough; Ian N Moore; Sundar Ganesan; Cedar J Fowler; Arian Laurence; Mary Garofalo; Douglas B Kuhns; Mark D Kieh; Arhum Saleem; Pamela A Welch; Dirk A Darnell; John I Gallin; Alexandra F Freeman; Steven M Holland; Sandip K Datta
Journal:  J Clin Invest       Date:  2018-07-23       Impact factor: 14.808

8.  IGFBP2 Activates the NF-κB Pathway to Drive Epithelial-Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma.

Authors:  Song Gao; Yan Sun; Xuebin Zhang; Limei Hu; Yuexin Liu; Corrine Yingxuan Chua; Lynette M Phillips; He Ren; Jason B Fleming; Huamin Wang; Paul J Chiao; Jihui Hao; Wei Zhang
Journal:  Cancer Res       Date:  2016-09-22       Impact factor: 12.701

Review 9.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

10.  The transcriptional repressor ZBP-89 and the lack of Sp1/Sp3, c-Jun and Stat3 are important for the down-regulation of the vimentin gene during C2C12 myogenesis.

Authors:  Morgan Salmon; Zendra E Zehner
Journal:  Differentiation       Date:  2009-02-23       Impact factor: 3.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.